Funaro Kimberly, Ataya Dana, Niell Bethany
Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA; Department of Oncologic Sciences, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA; Department of Oncologic Sciences, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Radiol Clin North Am. 2021 Jan;59(1):41-55. doi: 10.1016/j.rcl.2020.09.009. Epub 2020 Nov 2.
Screening mammography aims to identify small, node-negative breast cancers when they are still curable while maintaining an acceptable range of false-positive recalls and biopsies. The mammography audit is a powerful tool to help radiologists understand their performance with respect to that goal. This article defines audit terms and describes how to use collected and derived data to perform a mammography audit. Accepted benchmarks are discussed as well as their applicability to radiologists and breast imaging practices in the United States. Special considerations regarding volumes and radiologist characteristics are explored, because these factors may affect audit results.
乳腺钼靶筛查旨在在小的、无淋巴结转移的乳腺癌仍可治愈时将其识别出来,同时保持假阳性召回和活检在可接受范围内。乳腺钼靶审核是一种有力工具,可帮助放射科医生了解他们在该目标方面的表现。本文定义了审核术语,并描述了如何使用收集和推导的数据进行乳腺钼靶审核。讨论了公认的基准及其在美国对放射科医生和乳腺影像实践的适用性。探讨了关于病例量和放射科医生特征的特殊考虑因素,因为这些因素可能会影响审核结果。